Standard
Application of interpretable artificial neural networks to early monoclonal antibodies development. / Gentiluomo, Lorenzo; Roessner, Dierk; Augustijn, Dillen; Svilenov, Hristo; Kulakova, Alina; Mahapatra, Sujata; Winter, Gerhard; Streicher, Werner; Rinnan, Åsmund; Peters, Günther H. J.; Harris, Pernille; Friess, Wolfgang.
I:
European Journal of Pharmaceutics and Biopharmaceutics, Bind 141, 2019, s. 81-89.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Gentiluomo, L, Roessner, D, Augustijn, D, Svilenov, H, Kulakova, A, Mahapatra, S, Winter, G, Streicher, W
, Rinnan, Å, Peters, GHJ, Harris, P & Friess, W 2019, '
Application of interpretable artificial neural networks to early monoclonal antibodies development',
European Journal of Pharmaceutics and Biopharmaceutics, bind 141, s. 81-89.
https://doi.org/10.1016/j.ejpb.2019.05.017APA
Gentiluomo, L., Roessner, D., Augustijn, D., Svilenov, H., Kulakova, A., Mahapatra, S., Winter, G., Streicher, W.
, Rinnan, Å., Peters, G. H. J., Harris, P., & Friess, W. (2019).
Application of interpretable artificial neural networks to early monoclonal antibodies development.
European Journal of Pharmaceutics and Biopharmaceutics,
141, 81-89.
https://doi.org/10.1016/j.ejpb.2019.05.017Vancouver
Gentiluomo L, Roessner D, Augustijn D, Svilenov H, Kulakova A, Mahapatra S o.a.
Application of interpretable artificial neural networks to early monoclonal antibodies development.
European Journal of Pharmaceutics and Biopharmaceutics. 2019;141:81-89.
https://doi.org/10.1016/j.ejpb.2019.05.017Author
Gentiluomo, Lorenzo ; Roessner, Dierk ; Augustijn, Dillen ; Svilenov, Hristo ; Kulakova, Alina ; Mahapatra, Sujata ; Winter, Gerhard ; Streicher, Werner ; Rinnan, Åsmund ; Peters, Günther H. J. ; Harris, Pernille ; Friess, Wolfgang. / Application of interpretable artificial neural networks to early monoclonal antibodies development. I: European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; Bind 141. s. 81-89.
Bibtex
@article{5cb4cef50a8442cabcbf6ac61c67a925,
title = "Application of interpretable artificial neural networks to early monoclonal antibodies development",
keywords = "Neural network(s), Machine learning, Protein aggregation, Protein formulation, Monoclonal antibody, Stability",
author = "Lorenzo Gentiluomo and Dierk Roessner and Dillen Augustijn and Hristo Svilenov and Alina Kulakova and Sujata Mahapatra and Gerhard Winter and Werner Streicher and {\AA}smund Rinnan and Peters, {G{\"u}nther H. J.} and Pernille Harris and Wolfgang Friess",
year = "2019",
doi = "10.1016/j.ejpb.2019.05.017",
language = "English",
volume = "141",
pages = "81--89",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
}
RIS
TY - JOUR
T1 - Application of interpretable artificial neural networks to early monoclonal antibodies development
AU - Gentiluomo, Lorenzo
AU - Roessner, Dierk
AU - Augustijn, Dillen
AU - Svilenov, Hristo
AU - Kulakova, Alina
AU - Mahapatra, Sujata
AU - Winter, Gerhard
AU - Streicher, Werner
AU - Rinnan, Åsmund
AU - Peters, Günther H. J.
AU - Harris, Pernille
AU - Friess, Wolfgang
PY - 2019
Y1 - 2019
KW - Neural network(s)
KW - Machine learning
KW - Protein aggregation
KW - Protein formulation
KW - Monoclonal antibody
KW - Stability
U2 - 10.1016/j.ejpb.2019.05.017
DO - 10.1016/j.ejpb.2019.05.017
M3 - Journal article
C2 - 31112768
VL - 141
SP - 81
EP - 89
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
SN - 0939-6411
ER -
